WST — WEST PHARMACEUTICAL SVSC INC

Ownership history in William Allan Corp  ·  7 quarters on record

This page tracks every 13F SEC filing in which William Allan Corp reported a position in WEST PHARMACEUTICAL SVSC INC (WST). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.05% (2025 Q4)
Avg. % of fund
1.47%
First filed
2024 Q2
Last filed
2025 Q4
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 13,163 -659 -4.8% 2.05% $3.6M $274.89
2025 Q3 REDUCED 13,822 -457 -3.2% 2.03% $3.6M $261.88
2025 Q2 ADDED 14,279 +3,556 +33.2% 1.82% $3.1M $218.25
2025 Q1 ADDED 10,723 +3,340 +45.2% 1.51% $2.4M $223.09
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    WST price (monthly, adj. close)

Other funds also holding WST

As of 2025 Q4 — sorted by position size

Alpine Peaks Capital, LP 3Y 6.94% Seilern Investment Management Ltd 5.94% McCollum Christoferson Group LLC 3Y 7Y 3.27% Longview Partners (Guernsey) LTD 3Y 7Y 3.25% GENERATION INVESTMENT MANAGEMENT LLP 3Y 7Y 2.98% AMI ASSET MANAGEMENT CORP 3Y 7Y 2.48% Findlay Park Partners LLP 3Y 7Y 2.34% GRACE & WHITE INC /NY 3Y 7Y 2.14% STEADFAST CAPITAL MANAGEMENT LP 3Y 7Y 2.03% Brendel Financial Advisors LLC 3Y 7Y 1.84%
← Back to William Allan Corp Holdings